We are live on
!
Find out more
VU
Valence8 US Portfolio holdings
AUM
$286M
1-Year Est. Return
22.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.78%
1 Year Est. Return
+22.37%
3 Year Est. Return
+53.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$337M
AUM Growth
+$45.8M
(+16%)
Cap. Flow
+$36.9M
Cap. Flow
% of AUM
10.92%
Top 10 Holdings %
Top 10 Hldgs %
93.46%
Holding
15
New
1
Increased
9
Reduced
4
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$38.2M |
| 2 |
PWRD
TCW Transform Systems ETF
PWRD
|
+$16.2M |
| 3 |
VanEck Semiconductor ETF
SMH
|
+$5M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$403K |
| 5 |
iShares MSCI Intl Quality Factor ETF
IQLT
|
+$297K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Value ETF
VTV
|
+$9.3M |
| 2 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$7M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$3.79M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$3.4M |
Sector Composition
| Rank | Sector | Weight |
|---|
Similar funds
A
MC
IRAG
4WM
MAG
HMP
SIIL
LCM
Valence8 US's Q4 2025 Portfolio in Review
As of Q4 2025, Valence8 US held 15 positions worth $337M, up 16% from $292M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Valence8 US deployed $36.9M of net new capital in Q4 2025, opening 1 new position and adding to 9 existing holdings. Its largest new stake was TCW Transform Systems ETF: 164,850 shares worth $15.9M.
On the sell side, the largest reduction was Vanguard Value ETF, an estimated $9.3M trimmed.
- Valence8 US's largest Q4 2025 buy was TCW Transform Systems ETF: 164,850 shares worth $15.9M.
- Valence8 US added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q4 2025, an estimated $38.2M increase.
- Valence8 US's biggest Q4 2025 reduction was Vanguard Value ETF, cutting an estimated $9.3M.
- Valence8 US's ten largest holdings make up 93% of its $337M portfolio in Q4 2025.
- Valence8 US opened 1 new position and closed 0 in Q4 2025.
- Valence8 US's portfolio value rose 16% quarter-over-quarter to $337M.
Based on Valence8 US's 13F filing for Q4 2025, filed 9 Feb 2026.